SM
MDCO

Sciencast Management’s Medicines Co MDCO Stock Holding History

Sciencast Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-8,983
Closed -$228K – 386
2018
Q3 		$228K Buy
+8,983
New +$338K 0.15% 232
2017
Q2 		– Sell
-6,100
Closed -$298 – 529
2017
Q1 		$298 Buy
+6,100
New +$278K 0.16% 211

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Sciencast Management's MDCO Position: Q4 2018 in Review

Sciencast Management sold out of Medicines Co (MDCO) in Q4 2018, closing a stake of 8,983 shares — an estimated $228K sold.

Sciencast Management first reported a position in MDCO in Q1 2017 and held it in 2 quarters. The position peaked at $228K in Q3 2018. 188 funds tracked by Wall St. Rank hold MDCO as of Q4 2018.

  • Sciencast Management reported no remaining Medicines Co position as of Q4 2018 after selling out during the quarter.
  • Sciencast Management sold 8,983 Medicines Co shares in Q4 2018, an estimated $228K.
  • Sciencast Management first reported a position in Medicines Co in Q1 2017 and held it in 2 quarters.
  • Sciencast Management's Medicines Co position peaked at $228K in Q3 2018.
  • 188 funds tracked by Wall St. Rank held Medicines Co as of Q4 2018.

Based on Sciencast Management's 13F filing for Q4 2018, filed 14 Feb 2019.